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See related letter by Donadio, http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1198-4.The recently published data of Donadio in Critical Care
provide convincing evidence that neutrophil gelatinase-
associated lipocalin (NGAL), an established key bio-
marker of acute kidney injury (AKI) in the critically ill,
can be effectively removed by renal replacement therapy
(RRT) [1]. His findings challenge recent work by
Schilder et al. [2] and corroborate our concern regarding
the potential removal of NGAL during continuous RRT
(CRRT) [3]. NGAL is expected to be eliminated by con-
vection because its molecular weight (MW) lies below
the 30-kDa MW cutoff point of “classic” dialysis mem-
branes. Schilder et al. found almost no clearance of NGAL
during continuous veno-venous hemofiltration despite
using a 40-kDa MW (high) cutoff cellulose triacetate filter
[2]. Donadio used the same filter in patients undergoing
high-flux maintenance hemodialysis (MHD) but applied
an ultrafiltration rate more than twice as high as that of
Schilder et al. (8474 versus 3700 ml/h per 100 mm Hg)
and a higher sieving coefficient for middle molecules [4].
Moreover, Donadio observed that hemodiafiltration
(HDF) largely outperformed high-flux MHD in plasma
NGAL removal (52.1 % versus 26.7 % reduction ratio) [4].
This could be explained by a difference in membrane type.
Cellulose triacetate filters have very poor adsorption cap-
acity [5]. In contrast, the acrylonitrile (AN) and natrium
metallylsulfone copolymer membrane used for MHD in
the Donadio study has characteristics similar to those of
the highly adsorptive AN69 surface-treated membrane
used for CRRT in critically ill patients [5]. As this filter
displays a lower MW cutoff than that of cellulose triacet-
ate (30 versus 40 kDa), the remarkable removal of NGAL
from plasma in patients undergoing HDF is not explained* Correspondence: patrick.honore@az.vub.ac.be
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itional membrane adsorption.
Taken together, the recent work [4] and comments
including the additional data [1] of Donadio underscore
that NGAL may lose significance to reflect severity and
prognosis of AKI in patients receiving RRT because in-
tensified convection or substantial adsorption (or both)
on currently used dialysis membranes enhances plasma
clearance of this biomarker.
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